Latest Breaking News On - Division of cardiovascular diseases - Page 1 : comparemela.com

Tenax Therapeutics to Host KOL Event: LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study

Tenax Therapeutics to Host KOL Event: LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Columbia universityNew yorkUnited statesJohns hopkins hospitalAmerican college of cardiologyCity of new yorkMayo clinic in rochesterHarvard universitySanjiv shahPatrickh lehanJaved butlerDaniel burkhoffCharlesa garganoJohn frauncesmanaging directorlifesciBaylor scott white research instituteInternational society for heart

Endovascular catheter opens blocked arteries deep within lungs

Endovascular catheter opens blocked arteries deep within lungs
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAl iskandariyahTemple university hospitalTurkey creekTemple universityLoyola university medical centerCornell universityNew britainInova alexandria hospitalMalcolm fosterRobert looksteinRiyaz bashirGregory piazzaKenneth ourielVladimir lakhter

Temple University Researchers Develop Artery-Clearing Catheter

Temple University Researchers Develop Artery-Clearing Catheter
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesInova alexandria hospitalCornell universityNew yorkNew britainTemple university hospitalLoyola university medical centerAl iskandariyahTurkey creekTemple universityRiyaz bashirGregory piazzaKenneth rosenfieldAmir darkiMalcolm fosterAkhilesh sista

Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial

Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

William grayStacy enxing sengDivision of cardiovascular diseasesProduct serviceCenters for medicare medicaid servicesNational principal investigatorContego medical incMain line healthMedical announces one year outcomes fromMedical incVascular interventional advancesSystem chiefCardiovascular diseasesCo national principal investigatorContego medicalMedicaid services

PERFORMANCE II Carotid Stent Trial One-Year Outcomes Released at VIVA23

Contego Medical Inc. announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual VIVA (Vascular InterVentional Advances), VIVA 23, being held Oct. 30-Nov. 2 in Las Vegas, NV. The PERFORMANCE II is a prospective, multicenter study evaluating the safety and effectiveness of the Neuroguard IEP System in 305 patients at 40 clinical sites.

Stacy enxing sengWilliam grayLas vegasContego medical incCenters for medicare medicaid servicesViva foundation octDivision of cardiovascular diseasesMain line healthNational principal investigatorContego medicalVascular interventional advancesAviva foundationSystem chiefCardiovascular diseasesCo national principal investigatorMedicaid services